Search Results - "ELIAS, D. A"

An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours by Schöffski, P, Adkins, D, Blay, J.-Y, Gil, T, Elias, A.D, Rutkowski, P, Pennock, G.K, Youssoufian, H, Gelderblom, H, Willey, R, Grebennik, D.O

“…Abstract Background Cixutumumab (IMC-A12), a fully human immunoglobulin G1 (IgG1) monoclonal antibody, exerts preclinical activity in several sarcoma models…”
Get full text

Clinical evaluation and MR imaging features of popliteal artery entrapment and cystic adventitial disease by ELIAS, D. A, WHITE, L. M, RUBENSTEIN, J. D, CHRISTAKIS, M, MERCHANT, N

Get full text

Novel Semiquantitative Bone Marrow Oedema Score and Fracture Score for the Magnetic Resonance Imaging Assessment of the Active Charcot Foot in Diabetes by Elias, D. A., Ramnarine, R., Briody, A., Isaac, A., Donaldson, Ana, Petrova, Nina L., Meacock, L., Edmonds, Michael E.

“…There are no accepted methods to grade bone marrow oedema (BMO) and fracture on magnetic resonance imaging (MRI) scans in Charcot osteoarthropathy. The aim was…”
Get full text

The value of ultrasound in assessing displacement of a medial clavicular physeal separation in an adolescent by Deganello, A., Meacock, L., Tavakkolizadeh, A., Sinha, J., Elias, D. A.

“…We describe a case of medial clavicular physeal separation with posterior displacement of the metaphysis in a 13-year-old girl, focusing on the role played by…”
Get full text

Characterization of Microbial Activities and U Reduction in a Shallow Aquifer Contaminated by Uranium Mill Tailings by D. A. Elias, L. R. Krumholz, Wong, D., Long, P. E., J. M. Suflita

“…A characterization of the Shiprock, NM, uranium mill tailing site focused on the geochemical and microbiological factors governing in-situ uranium-redox…”
Get full text

Imaging of patellofemoral disorders by Elias, D.A, White, L.M

“…Anterior knee pain is a common symptom, which may have a large variety of causes including patellofemoral pathologies. Patellofemoral maltracking refers to…”
Get full text

Generalized Schemes for High-Throughput Manipulation of the Desulfovibrio vulgaris Genome by CHHABRA, S. R, BUTLAND, G, REVECO, S, ZANE, G. M, SEMKIW, E, PRATHAPAM, R, GOLD, B, SINGER, M, OUELLET, M, SZAKAL, E. D, JORGENS, D, PRICE, M. N, ELIAS, D. A, WITKOWSKA, H. E, BELLER, H. R, ARKIN, A. P, HAZEN, T. C, BIGGIN, M. D, AUER, M, WALL, J. D, KEASLING, J. D, CHANDONIA, J.-M, FORK, O.-Y, JUBA, T. R, GORUR, A, ALLEN, S, LEUNG, C. M, KELLER, K. L

“…Classifications Services AEM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Impact of hydrologic boundaries on microbial planktonic and biofilm communities in shallow terrestrial subsurface environments by Smith, H J, Zelaya, A J, De León, K B, Chakraborty, R, Elias, D A, Hazen, T C, Arkin, A P, Cunningham, A B, Fields, M W

“…Subsurface environments contain a large proportion of planetary microbial biomass and harbor diverse communities responsible for mediating biogeochemical…”
Get full text

Small cell lung cancer: state-of-the-art therapy in 1996 by Elias, A D

“…Small cell lung cancer (SCLC) occurs almost exclusively in smokers and represents 15 to 25% of all lung cancer histologic findings. It is distinguished from…”
Get more information

Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials by Marczyk, M., Mrukwa, A., Yau, C., Wolf, D., Chen, Y.-Y., Balassanian, R., Nanda, R., Parker, B.A., Krings, G., Sattar, H., Zeck, J.C., Albain, K.S., Boughey, J.C., Liu, M.C., Elias, A.D., Clark, A.S., Venters, S.J., Shad, S., Basu, A., Asare, S.M., Buxton, M., Asare, A.L., Rugo, H.S., Perlmutter, J., DeMichele, A.M., Yee, D., Berry, D.A., Veer, L. van’t, Symmans, W.F., Esserman, L., Pusztai, L.

“…Difference in pathologic complete response (pCR) rate after neoadjuvant chemotherapy does not capture the impact of treatment on downstaging of residual cancer…”
Get full text

Treatment of severe veno-occlusive disease with defibrotide : Compassionate use results in response without significant toxicity in a high-risk population by RICHARDSON, P. G, ELIAS, A. D, SOIFFER, R, VREDENBURGH, J, LILL, M, WOOLFREY, A. E, BEARMAN, S. I, LACOBELLI, M, FAREED, J, GUINAN, E. C, KRISHNAN, A, WHEELER, C, NATH, R, HOPPENSTEADT, D, KINCHLA, N. M, NEUBERG, D, WALLER, E. K, ANTIN, J. H

“…Hepatic veno-occlusive disease (VOD) is the most common of the regimen-related toxicities accompanying stem cell transplantation (SCT). Despite aggressive…”
Get full text

Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC) by Elias, A.D., Skarin, A.T., Leong, T., Mentzer, S., Strauss, G., Lynch, T., Shulman, L., Jacobs, C., Abner, A., Baldini, E.H., Frei, E., Sugarbaker, D.J.

“…Introduction: Neoadjuvant therapy in patients with Stage IIIA NSCLC is associated with a 50–70% resection rate and a 3–5 year survival of 20–32%, but few…”
Get full text

Mechanisms of injury and CT findings in bowel and mesenteric trauma by Khan, I, Bew, D, Elias, D.A, Lewis, D, Meacock, L.M

“…Bowel and mesenteric injuries are relatively uncommon but associated with significant morbidity and mortality. Early recognition is crucial, and multidetector…”
Get full text

High-dose therapy for adult soft tissue sarcoma: dose response and survival by Elias, A D

“…The role for high-dose therapy in the treatment of sarcomas is controversial and limited. Numerous trials in soft tissue sarcomas have suggested dose-response…”
Get more information

Mobilization of Peripheral Blood Progenitor Cells by Chemotherapy and Granulocyte-Macrophage Colony-Stimulating Factor for Hematologic Support After High-Dose Intensification for Breast Cancer by Elias, Anthony D., Ayash, Lois, Anderson, Kenneth C., Hunt, Myla, Wheeler, Cathy, Schwartz, Gary, Tepler, Isidore, Mazanet, Rosemary, Lynch, Cathy, Pap, Stephen, Pelaez, Jorge, Reich, Elaine, Critchlow, Jonathan, Demetri, George, Bibbo, Judy, Schnipper, Lowell, Griffin, James D., III, Emil Frei, Antman, Karen H.

“…High-dose therapy with autologous marrow support results in durable complete remissions in selected patients with relapsed lymphoma and leukemia who cannot be…”
Get full text

Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering by Webb, I J, Coral, F S, Andersen, J W, Elias, A D, Finberg, R W, Nadler, L M, Ritz, J, Anderson, K C

“…It is important to compare the incidence of bacterial contamination of components collected from the peripheral blood or bone marrow (BM), as well as of…”
Get more information

Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic by Demetri, G D, Elias, A D

“…Cytotoxic chemotherapy remains the principal modality of treating advanced or unresectable sarcomas of soft tissue. Certain drugs, such as doxorubicin and…”
Get more information

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer by ELIAS, A. D, RICHARDSON, P, WHEELER, C, FREI, E. III, AYASH, L, AVIGAN, D, IBRAHIM, J, JOYCE, R, DEMETRI, G, LEVINE, J, WARREN, D, ARTHUR, T, REICH, E

“…A single cycle of high-dose chemotherapy with stem cell support (HDC) in women with responsive metastatic breast cancer (BC) consistently achieves over 50%…”
Get full text

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies by ELIAS, A. D, RICHARDSON, P, FREI, E. III, AVIGAN, D, IBRAHIM, J, JOYCE, R, MCDERMOTT, D, LEVINE, J, WARREN, D, MCCAULEY, M, WHEELER, C

“…Two cycles of high-dose chemotherapy with stem cell support (HDC) may increase the total dose delivered and dose intensity. A brief induction phase and…”
Get full text

Salvage therapy for soft tissue sarcomas by Elias, A D

“…The clinical management of sarcomas, tumors of the connective tissue, is complicated by their relative rarity and pathologic heterogeneity. Adequate first-line…”
Get more information